BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 33752395)

  • 41. Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: A systematic literature review and meta-analysis.
    Morselli-Labate AM; Pezzilli R
    J Gastroenterol Hepatol; 2009 Jan; 24(1):15-36. PubMed ID: 19067780
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of histological features resembling autoimmune pancreatitis in neoplastic pancreas resections.
    Chen L; Orr CE; Wang T
    Histopathology; 2020 Oct; 77(4):673-677. PubMed ID: 32608526
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical and pathological differences between serum immunoglobulin G4-positive and -negative type 1 autoimmune pancreatitis.
    Paik WH; Ryu JK; Park JM; Song BJ; Park JK; Kim YT; Lee K
    World J Gastroenterol; 2013 Jul; 19(25):4031-8. PubMed ID: 23840149
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autoimmune pancreatitis: Biopsy interpretation and differential diagnosis.
    Zen Y
    Semin Diagn Pathol; 2024 Mar; 41(2):79-87. PubMed ID: 38184420
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autoimmune Pancreatitis and Immunoglobulin G4-related Sclerosing Cholangitis: Past, Present, and Future.
    Moon SH; Kim MH
    Korean J Gastroenterol; 2022 Sep; 80(3):107-114. PubMed ID: 36156034
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum IgG4 levels and extrapancreatic lesions in autoimmune pancreatitis.
    Kamisawa T; Imai M; Egawa N; Tsuruta K; Okamoto A
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1167-70. PubMed ID: 18936710
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pitfalls of diagnosing autoimmune pancreatitis.
    Frajerová D
    Vnitr Lek; 2021; 67(E-7):24-27. PubMed ID: 35459354
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IgG4-related disease: with emphasis on the biopsy diagnosis of autoimmune pancreatitis and sclerosing cholangitis.
    Detlefsen S; Klöppel G
    Virchows Arch; 2018 Apr; 472(4):545-556. PubMed ID: 29196804
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serum level of Ca 19-9 increases ability of IgG4 test to distinguish patients with autoimmune pancreatitis from those with pancreatic carcinoma.
    van Heerde MJ; Buijs J; Hansen BE; de Waart M; van Eijck CH; Kazemier G; Pek CJ; Poley JW; Bruno MJ; Kuipers EJ; van Buuren HR
    Dig Dis Sci; 2014 Jun; 59(6):1322-9. PubMed ID: 24385012
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of serum IFN-α and IL-33 as novel biomarkers for type 1 autoimmune pancreatitis and IgG4-related disease.
    Minaga K; Watanabe T; Hara A; Kamata K; Omoto S; Nakai A; Otsuka Y; Sekai I; Yoshikawa T; Yamao K; Takenaka M; Chiba Y; Kudo M
    Sci Rep; 2020 Sep; 10(1):14879. PubMed ID: 32938972
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The sensitivity and specificity of serum immunoglobulin G and immunoglobulin G4 levels in the diagnosis of autoimmune chronic pancreatitis: Korean experience.
    Choi EK; Kim MH; Lee TY; Kwon S; Oh HC; Hwang CY; Seo DW; Lee SS; Lee SK
    Pancreas; 2007 Aug; 35(2):156-61. PubMed ID: 17632322
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autoimmune pancreatitis: a guide for the histopathologist.
    Shinagare S; Shinagare AB; Deshpande V
    Semin Diagn Pathol; 2012 Nov; 29(4):197-204. PubMed ID: 23068298
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autoimmune pancreatitis and pancreatic cancer: Epidemiological aspects and immunological considerations.
    Poddighe D
    World J Gastroenterol; 2021 Jul; 27(25):3825-3836. PubMed ID: 34321847
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Case of Type 1 Autoimmune Pancreatitis (AIP), a Form of IgG4-Related Disease (IgG4-RD).
    El Euch M; Hddad S; Mahfoudhi M; Maktouf H; Ben Hamida F; Jaziri F; Ben Abdelghani K; Turki S; Ben Abdallah T
    Am J Case Rep; 2017 Jul; 18():822-825. PubMed ID: 28736430
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autoimmune pancreatitis in the paediatric population - review of the literature and own experience.
    Kołodziejczyk E; Wejnarska K; Oracz G
    Dev Period Med; 2016; 20(4):279-286. PubMed ID: 28216481
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Autoimmune pancreatitis.
    Detlefsen S; Drewes AM
    Scand J Gastroenterol; 2009; 44(12):1391-407. PubMed ID: 19958057
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience.
    Chari ST; Smyrk TC; Levy MJ; Topazian MD; Takahashi N; Zhang L; Clain JE; Pearson RK; Petersen BT; Vege SS; Farnell MB
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1010-6; quiz 934. PubMed ID: 16843735
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pancreatic cancer in patients with autoimmune pancreatitis: A scoping review.
    Macinga P; Bajer L; Del Chiaro M; Chari ST; Dite P; Frulloni L; Ikeura T; Kamisawa T; Kubota K; Naitoh I; Okazaki K; Pezzilli R; Vujasinovic M; Spicak J; Hucl T; Lӧhr M
    Pancreatology; 2021 Aug; 21(5):928-937. PubMed ID: 33775564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [IgG4-related systemic disease with autoimmune pancreatitis and lung involvement primarily presenting as pancreatic cancer with pulmonary metastases].
    Schmitz D; Klöppel G; Esinger W; Niemeyer J; Pottmeyer A; Grosse A
    Z Gastroenterol; 2013 Mar; 51(3):290-5. PubMed ID: 23487358
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metachronous Development of Peritoneal Carcinomatosis in a Patient with Autoimmune Pancreatitis.
    Lee KW; Chang JH; Kim J; Kim TH; Kim CW; Kim JK; Han SW
    Korean J Gastroenterol; 2020 Jun; 75(6):356-361. PubMed ID: 32581208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.